Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

BPL Ltd

Pharmaceuticals & Biotechnology | Small Cap

BPL Ltd Health Insights
Health Score : 5.46Health Score : 5.46

BPL Ltd, operating in the consumer durables sector, demonstrates a mixed financial performance. The company shows strong solvency and profitability, driven by a healthy equity position and solid margins. Revenue and asset growth are positive, indicating market expansion. However, liquidity is a concern, with low current and cash ratios. Efficiency is also mixed, with good inventory management but challenges in asset utilization and receivable collection. While interest coverage is adequate, the absence of dividend coverage is a notable weakness. Overall, BPL showcases potential with its growth and profitability, but needs to address liquidity and efficiency to ensure sustainable financial health. Recent capital expenditure may be a cause for concern.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
BPL Ltd Health Insights
Health Score : 5.46Health Score : 5.46

BPL Ltd, operating in the consumer durables sector, demonstrates a mixed financial performance. The company shows strong solvency and profitability, driven by a healthy equity position and solid margins. Revenue and asset growth are positive, indicating market expansion. However, liquidity is a concern, with low current and cash ratios. Efficiency is also mixed, with good inventory management but challenges in asset utilization and receivable collection. While interest coverage is adequate, the absence of dividend coverage is a notable weakness. Overall, BPL showcases potential with its growth and profitability, but needs to address liquidity and efficiency to ensure sustainable financial health. Recent capital expenditure may be a cause for concern.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

-18.28

Highly Undervalued

Industry Median

28.93

Highly Undervalued
Highly Undervalued

Small Cap Median

26.92

Highly Undervalued

P/E RATIO

-31.34

P/B RATIO

1.11

Highly Undervalued

Industry Median

3.18

Highly Undervalued
Undervalued

Small Cap Median

2.63

Undervalued

P/S RATIO

3.47

Neutral

Industry Median

3.41

Neutral
Overvalued

Small Cap Median

2.40

Overvalued

Others

Neutral

PEG RATIO

0.00

Neutral
Highly Undervalued

EV/EBITDA RATIO

-119.17

Highly Undervalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹54.84 as on Jun 18, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 6.00

The company demonstrates strong revenue and asset growth, along with a significant increase in operating profit. However, earnings per share and net income growth are negative, indicating potential issues with profitability despite revenue gains. Overall, the company is expanding its operations, but profitability needs to catch up with revenue growth. The company has potential to grow, but profitability is a major concern.

ExcellentRevenue Growth RateExcellent
ExcellentOperating Profit Growth RateExcellent
PoorEarnings Per Share (EPS) GrowthPoor
ExcellentAsset Growth RateExcellent
PoorNet Income Growth RatePoor
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate36.5227.2117.96-0.31
Operating Profit Growth Rate4446.15142.3-12.57-138.5
Earnings Per Share (EPS) Growth-61.13168.93-98.19-3600
Asset Growth Rate11.732.86-0.5616.44
Net Income Growth Rate-60.93165.02-99.25-8650
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 2.40

The company's financial ratios indicate a mixed performance. While cash earnings per share are positive, adjusted earnings per share and book value per share are relatively low. The company is not paying dividends, and capital expenditures are high, suggesting significant investments. Overall, the company is making investments, but returns are not yet reflected in earnings. Recent capital expenditure may be a cause for concern.

PoorAdjusted Earnings Per Share (Adjusted EPS)Poor
WeakCash Earnings Per Share (Cash EPS)Weak
PoorBook Value Per SharePoor
PoorDividend Per Share (DPS)Poor
PoorCapital Expenditures (CapEx)Poor
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)2.651.032.74-18.76-1.74
Cash Earnings Per Share (Cash EPS)2.991.383.140.49-1.25
Book Value Per Share33.9748.1650.9250.8949.19
Dividend Per Share (DPS)00000
Capital Expenditures (CapEx)0.24.2647.90.3
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 9.20

The company's profitability ratios are generally strong, with good gross profit, ROCE, ROE, and operating and net margins. However, return on assets is relatively low, indicating potential inefficiencies in asset utilization. Overall, the company is profitable, but there is room to improve asset management. The company is in a very good shape in terms of profitability. The company can focus on improving its asset management.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
PoorReturn on Assets (ROA)Poor
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin-4.038.0818.5613.06-9.27
Return on Capital Employed (ROCE)5.623.864.354.91-1.22
Return on Equity (ROE)7.82.145.370.04-3.55
Return on Assets (ROA)0.020.992.322.04-0.68
Operating Margin0.3411.3221.5615.98-6.17
Net Margin33.869.6920.190.13-10.94
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 5.00

The company's efficiency ratios present a mixed picture. Inventory management is strong, but fixed asset and capital turnover are low, indicating underutilization of assets. Receivable collection is also slow, suggesting potential issues with credit policies. Overall, there is room to improve asset utilization and working capital management. The company can focus on improving the turnover ratio to increase efficiency.

PoorFixed Asset Turnover RatioPoor
ExcellentInventory Turnover RatioExcellent
WeakReceivables Turnover RatioWeak
ExcellentDays Sales in Inventory RatioExcellent
PoorReceivable DaysPoor
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio0.690.91.111.281.32
Inventory Turnover Ratio6.639.612.0213.6312.19
Receivables Turnover Ratio2.933.873.83.483.19
Days Sales in Inventory Ratio55.0538.0230.3726.7829.94
Receivable Days124.5394.3296.05104.89114.42
Capital Turnover Ratio0.230.220.260.310.23
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 6.80

The company exhibits strong interest coverage, indicating a healthy ability to meet its interest obligations. However, the lack of equity dividend coverage is a notable weakness, suggesting that the company is not providing returns to its equity holders. The company is stable in terms of interest coverage. But the company is not providing returns to its equity holders.

ExcellentInterest Coverage RatioExcellent
PoorEquity Dividend Coverage RatioPoor
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio5.49.1222.091.07-3.8
Equity Dividend Coverage Ratio
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The company's solvency position is very strong, characterized by low debt levels and a high proportion of equity. This indicates a stable financial structure and reduced risk of financial distress. The company has a solid foundation for future growth and stability. This implies that the company is not taking on too much debt. Future expansion of the company using debt might be difficult.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio0.110.080.080.080.28
Debt to Equity Ratio0.120.090.090.090.39
Equity Ratio0.890.920.920.920.72
Debt To Asset Ratio0.040.040.040.040.13
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 2.40

The company's liquidity position reflects potential challenges in meeting its short-term obligations. While there is adequate operating cash flow, the low current and quick ratios suggest limited liquid assets. This indicates a need for improved working capital management to ensure smoother operations. Depending on short-term obligations, it can cause significant concern to the company. Despite these challenges, the company is able to generate some cash from its operation.

PoorCurrent RatioPoor
PoorQuick RatioPoor
PoorCash RatioPoor
WeakOperating Cash Flow RatioWeak
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio0.320.320.350.350.59
Quick Ratio0.310.30.330.330.56
Cash Ratio00.010.030.010.01
Operating Cash Flow Ratio00.020.020.03-0.23
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 13 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Medico Remedies Ltd6.6137.70Overvalued17.001.5813.00
2SMS Lifesciences India Ltd6.5921.78Neutral45.0070.6819.00
3Infinium Pharmachem Ltd6.4226.49Neutral22.006.4314.00
4Aarey Drugs & Pharmaceuticals Ltd5.7358.49Neutral7.001.404.00
5Albert David Ltd5.63-272.76Neutral5.00-2.62-1.00
6BPL Ltd5.46-31.34Neutral-4.82-3.00-8.55
7Zim Laboratories Ltd5.4141.96Neutral30.001.116.00
8Quest Laboratories Ltd5.2711.86Neutral18.009.1615.00
9Sotac Pharmaceuticals Ltd5.2721.26Neutral18.004.456.00
10Lyka Labs Ltd4.77-24.93Neutral-4.00-9.05-10.00
11Krebs Biochemicals & Industries Ltd4.16-5.14Highly Undervalued-4.00-12.49-4.00
12Nectar Lifescience Ltd3.83-2.67Neutral-59.00-2.95-293.00
Management Assessment Summary
OrangeBalanced Management

Management effectiveness presents a mixed picture. The company shows positive trends in sales growth but experiences volatility in net profit. Although sales have grown, profitability is inconsistent. Capital efficiency, as indicated by ROCE, has improved recently. Promoter holding remains stable, demonstrating continued alignment with shareholder interests. Debt management appears to be under control with lower borrowings, but there are fluctuations in working capital management. Overall, management demonstrates strengths in revenue generation and operational efficiency but needs to address profit volatility and working capital management for sustained financial health.

Category Metric Value Assessment
PROS Sales Growth 17.96% (Mar 2025) Revenue expansion is strong.
Operating Profit Margin 15.51% (Mar 2025) Operational efficiency is improving.
Promoter Holding 63.13% Confidence and alignment with shareholders.
CONS Net Profit Volatility -18 (Mar 2025) Financial performance is volatile.
Working Capital Days -675.13 (Mar 2025) Operational cycles are inefficient.
AverageFinancial Performance & GrowthAverage
GoodCapital Efficiency & ReturnsGood
GoodFinancial Health & PrudenceGood
AverageStrategic & Operational IndicatorsAverage
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Strategic & Operational Indicators

Risk Assessment Summary
OrangeBalanced Risk

The risk assessment for BPL Ltd. indicates a moderate level of risk, primarily due to inconsistent financial performance and operational inefficiencies. While the company has shown improvement in sales growth and capital efficiency, the volatility in net profit and working capital management raises concerns. The stable promoter holding and low debt levels are positive signs, but the absence of dividend payouts and fluctuations in operational cycles suggest potential areas of instability.

AverageOff-balance sheet exposure quantificationAverage
AverageContingent liability evaluationAverage
01.

Off-balance sheet exposure quantification

02.

Contingent liability evaluation

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 2 Hours Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 4 Hours Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 1 Day Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 1 Week Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 1 Month Timeframe